Thu, Apr 17, 2014, 4:42 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Pluristem Therapeutics, Inc. Message Board

povertysucks 116 posts  |  Last Activity: 7 hours ago Member since: Oct 1, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to


    by vinumalta Apr 14, 2014 1:51 PM povertysucks 7 hours ago Flag

    Any dividend paying stox, they ALL function the same:
    A) You must own by close of trading day the day BEFORE the xdiv date.
    B) This derives from the Record date. The Record date is two trading days after the xdiv date.Since it takes 3 business / trading days for a buy / sell to settle, then you must own, by trading close, one trading day before the xdiv date.

  • Reply to

    How Low Is Low?

    by povertysucks Apr 11, 2014 9:54 AM povertysucks Apr 11, 2014 1:55 PM Flag


  • Reply to

    Can not get out of ARR-PA right now

    by legionfullmetal7 Apr 11, 2014 10:29 AM povertysucks Apr 11, 2014 11:09 AM Flag

    Go read your Yahoo posts and read johnsonjoel's Yahoo posts.

    One can easily compare and contrast the two of you.

    johnsonjoel has clearly defined goals originating from how he thinks, his structured discipline.
    He obviously has rules to buy and rules to sell. He knows himself, what actions will work for him and which actions won't. He is not working against himself.

    legion's posts don't describe anything about you that I have just described about johnsonjoel.
    Go analyze yourself. I'm not trying to offend you, but you read like your own worst enemy.

    Everything in life that you experience derives from how you think.

    On my tax return, for occupation, I write gardener.
    In my garden I have stoxs, real estate, precious metal, antiques, collectibles, etc.
    When an asset matures, or just before maturity, I harvest it.
    I work on my structure and discipline in all facets of my life.

    There is always another stox, house, job, person, or whatever.

  • by povertysucks Apr 11, 2014 9:54 AM Flag

    I think this is going below 3.00 before it goes back over 4.00.

  • Reply to

    Second offering

    by wrgrace88888 Apr 6, 2014 3:29 PM povertysucks Apr 11, 2014 9:23 AM Flag

    It looks like goldfish made a typing error.

    19.50 vs 9.50.

  • Reply to

    Institutional ownership

    by randynmd Apr 9, 2014 12:43 PM povertysucks Apr 11, 2014 9:17 AM Flag

    I think, if there is a quorum, that the incentive proposal shall pass.

  • Reply to

    Institutional ownership

    by randynmd Apr 9, 2014 12:43 PM povertysucks Apr 9, 2014 5:12 PM Flag

    Again, the "INSIDERS" also possess a material % of the float.
    Therefore, they will vote YES.

    Does anybody know the current % the "INSIDERS" own?
    It is located usually on page 3 or 5 of the proxy book.

  • Reply to

    Approval Scenario

    by johnsonjoel1 Apr 8, 2014 6:33 AM povertysucks Apr 9, 2014 4:56 PM Flag

    No guessing is needed.

    This is nothing new for all public companies.
    Occassionally the retail stockholders vote in sufficient numbers to temporarily block the proposal.
    Temporarily because it will continue to be a future proxy propsal until it passes.

    The PPS is never affected by any incentive proposal being ratified.
    The reality upon the ratification are the following:
    A) The BOD and mgmt create sometimes absurd reasons why one or more of them can receive stox options.
    B) When stock options are granted and converted into C/S, this is an immediate dilution of the stockholders' equity ownership %.
    B1) This is similar to a secondary.
    C) Depending on the terms of the stock option, the option can immediately be converted into stock or there is a waiting period, Fortune 500 do this, for certain company goals to be met, or there can be a minimum time, 6, 12, 24 months, before the recipient can convert from an option to a stock.
    D) The recipient upon conversion can usually immediately SELL.
    E) This is how management becomes the dominant owners of smaller companies, and enormously wealthy.

    I forgot to include in a post 2 weeks ago about the larger funds, institutions, etc who always vote whatever the proxy proposals are, management and the BOD. They already possess a material quantity of C/S and they will always vote their substantial quantity to ratify whatever proposal.

    Usually, an upper mgmt stockholder will include a portion of his immense C/S quantity for sale to be included in a secondary that the company is issuing to an investor. Or one or more insiders frequently sell in smaller quantities.

    GREED is their dominant motivation and it is all legal.

    The occupation that people going to college for is not doctor or lawyer, but upper management and the Board of Directors. Their income easily exceeds almost all other occupations.

  • Reply to

    Second offering

    by wrgrace88888 Apr 6, 2014 3:29 PM povertysucks Apr 7, 2014 3:35 PM Flag

    Yes, maybe next year.

  • povertysucks Mar 28, 2014 9:59 AM Flag

    You were clear. I was not confused.
    In addition, without my having to read the proxy, I already know what it states. They are all written almost word for word identically.

    So you are not confused, I will state clearly that you do not comprehend what you are doing.

    I am not writing anymore about this.

  • povertysucks Mar 28, 2014 9:18 AM Flag

    I have not read the proxy.
    However, your response to my post states, "I would be much more inclined to support the initiative if the entirety of compensation was comprised of stock."
    Your quote from the proxy is a vote to increase their stock options from 2 mil to 15 mil.

    Go read what a rights offering is. That is how it used to function, until the corporate attorneys in the 1980s rewrote the proxy votes so the stockholders could vote away their "rights".

    The institutions, who owned the majority of the float, did vote away the stockholders "rights". This is basic to a stockholder's understanding what a stox is. Only older people who experienced this would remember this. Younger people don't know why they do what they do.

    You are example by voting yes to increase the "elites" stock option compensation.

  • Reply to

    Tomorrow is divi day.

    by kkakear Mar 27, 2014 5:17 PM povertysucks Mar 28, 2014 7:53 AM Flag

    The price did not drop last month, February.
    Depending on which company applied the DRIP, it was in the area of 4.28 - 4.32.

  • povertysucks Mar 28, 2014 7:49 AM Flag

    For over 20 years, I have ALWAYS, irregardless of whatever company, voted NO TO INCREASE OR APPROVE ANY EXECUTIVE COMPENSATION in any form.

    It always passes because the majority voting are institutions, funds, investment companies, etc.

    This is a direct dilution to your % of ownership in any company.
    Why should these "elite" be further compensated for doing their job?
    Because the company reached % milestones?
    This is how the"employee" becomes the dominant owner.

    If you are employed, are you receiving these excessive bonuses?

  • Reply to


    by trevordewane1981 Mar 26, 2014 12:04 PM povertysucks Mar 26, 2014 4:28 PM Flag

    I am not challenging your statement.

    FDA approval for this facility just happened.
    Four years ago, I did not think that FDA facility approval was a component of the equation.

    Four years ago, PSTI announced they were enlarging the Haifa facility.
    Think about what physical actions have actually been effected since then.

    The Haifa facility is a state of the art, which has been completed and NOW has FDA approval.
    PSTI has two partners.
    PSTI has multiple FDA trials ongoing.
    All of the patents they have obtained.
    The medical indications that PLX cells could potentially be successfull is constantly growing.
    I think Buteo posted a better list than I will.

    PSTI founders and executives have a thorough, long term plan, that they are executing.

    This Haifa facility could generate material revenue.
    If PSTI decides NOT to temporarily contract it out, then ask yourself why.

    Maybe, PSTI will be operating and producing for itself in the near term and doesn't want to lock themselves in a contract that will be preventing them from utilizing the facility.

    Keep going back to PSTI's L/T plans. Everyone can know what they are by seeing their accomplishments. Therefore, there are many more to come.
    Increasing T/S and issuing secondaries is part of that.

  • Reply to

    Keeping my powder dry

    by jaime9_2000 Mar 26, 2014 12:17 PM povertysucks Mar 26, 2014 3:53 PM Flag

    Earlier in Feb or March, allo replied to my first post about a secondary by stating the company has stated that all future FDA trials would be financed by partners and that PSTI has over 50 million in cash. Therefore, there will be no secondaries.

    So, no partner will be announced untill after this next secondary.

    The South Korean partner saw the potential and did the next best technique it could do with PSTI, be a partner. The 4.00 /sh did not matter to them. The money numbers moving around South Korea, in all of their industries, are astronomical, in the billions, a few million are inconsequential. The issue was getting it started and getting there first, before their competitors.

    None of this logic is complex.

    Everyone should enjoy the ride. The future shall be very interesting.

  • Reply to


    by trevordewane1981 Mar 26, 2014 12:04 PM povertysucks Mar 26, 2014 3:12 PM Flag

    I said this as long as four years ago, this "factory" can contract with other Biotechs to produce their products. Thereby, receiving material revenue.

    I have constantly posted here different realistic thoughts, that nobody ever comments about.
    And all of my posts, after the fact, are correct.

  • Reply to

    Keeping my powder dry

    by jaime9_2000 Mar 26, 2014 12:17 PM povertysucks Mar 26, 2014 2:51 PM Flag

    I have not read the proxy. I think you are misreading it when you state that they are "issuing" 100mil more shares. Rather they are increasing Treasury Stock by 100mil. Meaning, over time, there can be multiple secondaries.

    I think the next secondary will be issued to the investor around 3.00 - 3.15 Therefore, this PPS can go back under 2.80 untill more PRs over months contribute to adjusting the PPS back over 3.00 and higher.

    Simultaneously, are more warrants going to be issued with a longer expiration date? I think so.

    Warrants allow one high leverage as options do. They both expire, leaving zero valuation. Warrants can be converted into C / S at a materially higher PPS for C / S. Since a Biotech can constantly issue C /S how does the PPS reach that conversion point with constant dilution?

    All I can think of is FDA approval for public sale after all FDA requirements are met. Maybe I am wrong?

    Where did allo_geniec go?

  • Reply to

    ARR Scam Report Released

    by maurene.engelhart0616 Mar 23, 2014 8:13 PM povertysucks Mar 24, 2014 12:05 PM Flag

    deepsix, you can't find anything about a "stock scam research" because it does not exist.
    maurene-englehart Yahoo ID was created on March 23,2014.
    This is that one person who everyday is creating new Yahoo IDs to repost his penny stock website on all the different Yahoo MBs.

    This is his creative way to entice people to view his website.
    This is spam.

    What I don't understand is why Yahoo has not chased this penny stock schill legally for advertising for free on their website.

  • povertysucks Mar 21, 2014 11:36 AM Flag

    I forgot whether it was ARR or PSEC, but some people posted that another REIT was contemplating buying stock because the PPS was lower.

    The REIT can't do it because it would then no longer be a REIT. It would be an investment company mixed with being a reit. It would have to change it's status with the SEC. Maybe become a BDC.

    I think the same logic was discussed at an ARR BOD meeting.
    The BOD did not want to leave hundreds of millions of dollars in cash.
    They could not invest that huge amount in other companies and remain a REIT.
    So, they decided to temporarily park this money in ARR stox by buying it at a reduced mkt price.
    Some of it will be reissued after I/R increase and I expect at a higher mkt price at that time.

    I am now thinking about the tax consequence of that transaction. There would be a capital gain, but it's your stox, so I think there is no tax consequence. Anyone have a different thought?

    In the business cycle, when I/R are down, corporations call in the outstanding bonds and preferred stox and then reissue them at the lower interest rate. There is no such thing as a noncallable bond or preferred issue. Even though the underwriter advertises it that way. I only know one technique that allows the issuer to call in, but there are probably more.

    Legion, until I read your post I had forgotten about ARR's preferred. I know you own it.
    Logically, ARR should, in the future, announce the redemption of the O/S preferred, and then reissue it at a lower interest rate.

    With ARR's BOD buying ARR's c/s doesn't that imply that they are projecting a materially higher market PPS for whenever they decide to issue a secondary?

  • povertysucks Mar 21, 2014 10:26 AM Flag

    The company is only temporarily parking cash in buying C/S.
    DR cash / CR treasury stock.
    Later, maybe next year, they will reissue at a higher price, in a secondary, some of the c/s they bot at a lower price. After the Fed increases I/R, not necessarily the first increase, the company is waiting for the mortgage mkt to adjust to the then prevailing conditions.

    When preferred stock is redeemed or bot back by the company, it is not added to treasury stox.
    I'm guessing that they have decided to not call in the preferred issues because it has something to do with reissuing them. Maybe later this year, they will call in the preferred and reissue them before I/R increase.

3.54+0.06(+1.72%)4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.